The Value & Evidence Senior Manager is responsible for development and execution of high-quality Value & Evidence strategic efforts to support optimal access and reimbursement of Immuno-Oncology assets including Bavencio for the treatment of urothelial cancer, renal cell carcinoma, and merkel cell carcinoma.
This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of the approved uses of Bavencio.
This position will function with a ‘One Patient & Health Impact (PHI)’ mindset and will work in a closely aligned fashion with Oncology PHI team members to ensure there is a single and coordinated view on strategy and delivery from the PHI team to the Oncology business.
- Support the development of the Value & Evidence Strategy in close partnership with PHI and the cross-functional team
- Manage execution of clinically relevant and scientifically valid Value & Evidence studies and projects (including non-interventional studies, registries, etc) in alignment with the global Value & Evidence Strategy to demonstrate the value proposition catered to diverse stakeholders (regulators, payers, patients, physicians, and policy makers)
- Lead updates of tools including global value dossiers (GVDs), evidence blueprints, economic models, and innovative tools to support value proposition
- Develop real world evidence generation strategies and execute studies to support brand differentiation and value proposition
- Support the coordination of input from local country/regional H&V teams on evidence needs and ensure that input is appropriately incorporated to support demonstration of product value and optimize patient access
- Lead the development of data dissemination plans and communicate in a timely manner evidence generated to various stakeholders via publications and conference publications
- Master’s degree (MSc, MPH) in health services research, pharmacy administration/pharmaceutical policy, public health, or epidemiology, or health economics. Doctoral degree (PhD, DrPH, ScD) in relevant fields preferred.
- Minimum 2 years of experience with PhD/PharmD; minimum of 5 years of experience with MS/MPH, in early development, clinical trials, patient reported outcomes, and real world study design and implementation is desirable
- Knowledge and experience in the Oncology therapeutic area is preferred
- Demonstrated understanding of fundamental health services research methods (e.g., health economics, patient reported outcomes, research study design, database analyses, epidemiology, and statistics) and external environmental trends influencing health care/pharmaceuticals in key markets worldwide
- Demonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
- Excellent interpersonal skills required; ability to understand and respond to multiple internal and external customers and influence in a matrix environment
- Excellent oral and written English communication skills required
- Strong project management abilities (contracting, budgeting, vendor management) essential
- Skilled in functioning within a matrix organization where managing through influence is required
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Ability to travel domestically and internationally
Work Location Assignment:On Premise
Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.